Proteomics

Dataset Information

0

Human plasma LC-MSMS for predicting drug-response progonosis in depressed patients at 0, 1, 4 and 10 visiting weeks


ABSTRACT: Patients with major depressive disorder (MDD) have a high relapse rate and first prescribed selective serotonin reuptake inhibitors (SSRIs). The selection process of an antidepressant agent is primarily guided by trial and error. If patients do not benefit from the initial course of antidepressant medication for at least 4-6 weeks, additional therapeutic strategies are required to gain remission, including switching within and between classes of antidepressants. In order to discovery SSRI-related plasma protein markers, we designed a retrospective study. In this study, four longitudinal plasma samples were collected from 10 patients during the 10-week drug reaction period after being diagnosed with depression, and more than a thousand plasma proteins were identified by highly sensitive nanoflow liquid chromatography-tandem mass spectrometry (LC−MS/MS).

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Plasma

SUBMITTER: Kyunggon Kim  

LAB HEAD: Kyunggon Kim

PROVIDER: PXD017211 | Pride | 2020-11-03

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
181011_Leaders_11_1_E01.raw Raw
181011_Leaders_11_1_E02.raw Raw
181011_Leaders_11_1_E04.raw Raw
181011_Leaders_11_2_E01.raw Raw
181011_Leaders_11_2_E02.raw Raw
Items per page:
1 - 5 of 107
altmetric image

Publications

An Exploratory Pilot Study with Plasma Protein Signatures Associated with Response of Patients with Depression to Antidepressant Treatment for 10 Weeks.

Kim Eun Young EY   Ahn Hee-Sung HS   Lee Min Young MY   Yu Jiyoung J   Yeom Jeonghun J   Jeong Hwangkyo H   Min Hophil H   Lee Hyun Jeong HJ   Kim Kyunggon K   Ahn Yong Min YM  

Biomedicines 20201028 11


Major depressive disorder (MDD) is a leading cause of global disability with a chronic and recurrent course. Recognition of biological markers that could predict and monitor response to drug treatment could personalize clinical decision-making, minimize unnecessary drug exposure, and achieve better outcomes. Four longitudinal plasma samples were collected from each of ten patients with MDD treated with antidepressants for 10 weeks. Plasma proteins were analyzed qualitatively and quantitatively w  ...[more]

Similar Datasets

2021-06-07 | PXD023508 | Pride
2020-12-01 | PXD020557 | Pride
2014-06-01 | E-GEOD-53452 | biostudies-arrayexpress
2010-05-14 | E-GEOD-20470 | biostudies-arrayexpress
2014-09-11 | E-MTAB-2924 | biostudies-arrayexpress
2015-12-08 | E-GEOD-70812 | biostudies-arrayexpress
2010-11-05 | E-TABM-842 | biostudies-arrayexpress
2020-07-09 | PXD018851 | Pride
2011-09-23 | E-TABM-1075 | biostudies-arrayexpress
2004-10-31 | E-MEXP-29 | biostudies-arrayexpress